Group 1: Investor Relations Activities - The investor relations activities included a network meeting held from May 9 to May 12, 2025 [3] - Participating institutions included various securities firms and investment management centers [3] - Company representatives included the board secretary and securities affairs representative [3] Group 2: Financial Performance - The company reported a net profit loss for 2024, primarily due to the shutdown of a production line and asset impairment of CNY 28.292 million [4] - The company's operating revenue for 2024 was CNY 53.959 million, reflecting a year-on-year growth of 12.89% [5] Group 3: Production and Investment Projects - The subsidiary's production line for tetrahydrofuran has entered trial production, with stable operations expected to enhance profitability and market competitiveness [6] - Future optimization of the tetrahydrofuran production line is anticipated to positively impact the company's operational performance [6]
美邦科技(832471) - 投资者关系活动记录表